• / Free eNewsletters & Magazine
  • / My Account
Home>Cell Counting Market - Expected to Reach $1.7 Billion by 2025 - Research and Markets

Cell Counting Market - Expected to Reach $1.7 Billion by 2025 - Research and Markets

Cell Counting Market - Expected to Reach $1.7 Billion by 2025 - Research and Markets

10/02/2017

Cell Counting Market - Expected to Reach $1.7 Billion by 2025 - Research and Markets

The "Cell Counting Market, 2014-2025" report has been added to Research and Markets' offering.

The global cell counting market is expected to reach USD 1.7 billion by 2025.

Government initiatives working to promote development of cell therapeutics, wherein cell counting plays an imperative role, is expanding growth prospects for the market. As a result of extensive R&D activities, the number of diseases treated with the help of stem cells increased to 82 in 2016 from 27 in 2005. Also, California Institute for Regenerative Medicine's funding of USD 271 million for stem cell therapy created 12 R&D facilities in California, and these facilities brought approximately USD 543 million funding. In addition, it is also funded by National Institutes of Health (NIH), which approximately invested USD 1,429 million in 2015.

Increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided significant boost to the market. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate generation of accurate results are likely to improve adoption of instruments over the coming years. For instance, in May 2016, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve quality of preclinical studies.

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • PerkinElmer, Inc.
  • BD
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • GE Healthcare

Key Topics Covered:

Chapter 1 Research Methodology & Scope

©2017 Morningstar Advisor. All right reserved.